Vaccination of pregnant women with respiratory syncytial virus vaccine and protection of their infants.

Shabir A Madhi,Fernando P Polack,Pedro A Piedra,Flor M Munoz, Adrian A Trenholme,Eric Af Simoes,Geeta K Swamy,Khatija Ahmed,Abdullah H Baqui,Anna Calvert,Mark F Cotton,Clare L Cutland,Janet A Englund, Bernard Gonik,Laura Hammitt,Paul T Heath,Joanne N de Jesus, Christine E Jones,Asma Khalil,David W Kimberlin,Romina Libster,Marilla Lucero, Conrado J Llapur,Gonzalo Pérez Marc,Helen S Marshall,Federico Martinón-Torres,Terry M Nolan,Ayman Osman,Kirsten P Perret,Peter C Richmond,Matthew D Snape,Julie H Shakib,Tanya Stoney,Alan T Tita,Michael W Varner,Manu Vatish, Keith Vrbicky,Khalequ Zaman,Heather J Zar,Jennifer K Meece,Joyce S Plested,Sapeckshita Agrawal,Iksung Cho, Janice Chen,D Nigel Thomas,Judy Wen,Amy Fix, Allison August,Vivek Shinde,Gregory M Glenn,Louis F Fries

The New England journal of medicine（2020）

引用 203|浏览3

暂无评分

摘要

Funded by Novavax, with supporting grant from the Bill and Melinda Gates Foundation.

查看译文

关键词

efficacy,epidemiology,immunogenicity,infants,newborns,phase III trial,pneumonia,pregnancy,respiratory syncytial virus,safety,transplacental antibody transfer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要